Abdominal Aortic Aneurysm

An abdominal aortic aneurysm (AAA) is a condition characterized by a localized enlargement or ballooning of the abdominal aorta, the body’s largest artery, which carries blood from the heart to the lower body. This arterial dilation is defined as an increase in the aortic diameter of 50% or more, or an increase in the infrarenal diameter of 30 mm or more^[1]. AAA is a relatively common condition, particularly in older men, with a prevalence of up to 9% in men over 65 years of age ^[1]. It predominantly affects white populations ^[2]. Key risk factors for developing AAA include advanced age, male gender, smoking, atherosclerosis, and a family history of the condition^[1].

The biological basis of AAA involves a significant genetic component, alongside environmental and lifestyle factors. Studies, including twin studies, have estimated the heritability of AAA to be as high as 70%^[1]. Individuals with a first-degree relative affected by AAA have a substantially increased risk, ranging from 2- to 11-fold, of developing the condition themselves ^[2]. Recent research, particularly through genome-wide association studies (GWAS), has identified several specific genetic risk variants and loci associated with AAA susceptibility ^[1]. Notable examples include variants within the DAB2IP gene ^[1] and the LRP1 gene ^[2]. Furthermore, research indicates shared genetic risk factors between AAA and other types of aneurysms, such as intracranial and thoracic aneurysms ^[3].

Clinically, AAA is particularly challenging because most aneurysms remain asymptomatic until they are near rupture or actually rupture ^[1]. Aneurysm rupture is a catastrophic and often fatal event^[1]. The primary treatment strategy involves regular surveillance and, for aneurysms deemed at high risk of rupture (primarily based on size and growth rate), surgical repair^[1].

From a public health perspective, abdominal aortic aneurysm poses a serious and widespread threat. In the United States alone, AAA leads to more than 150,000 hospital admissions, approximately 40,000 surgical repair operations, and up to 15,000 deaths annually^[1]. The high mortality associated with rupture underscores the critical importance of early detection through screening programs and effective management strategies to prevent adverse outcomes and reduce the burden of this disease.

Limitations

Research into abdominal aortic aneurysm (AAA) has significantly advanced the understanding of its genetic underpinnings, yet several limitations persist in interpreting current findings and guiding future investigations. These limitations span methodological challenges, generalizability across diverse populations, and the complex interplay of genetic and environmental factors.

Methodological and Statistical Constraints

Studies on AAA face challenges related to phenotypic definition and measurement accuracy, which can impact statistical power and the reliability of genetic associations. For instance, the ascertainment of AAA, defined as an infrarenal aortic diameter of >30 mm, can vary between ultrasonography and cross-sectional imaging, with ruptured cases sometimes relying on an assumption of >5.5 cm diameter, potentially introducing heterogeneity ^[2]. Such phenotypic and study design heterogeneity can diminish statistical power to detect modest genetic effects, while measurement errors might bias estimates towards the null hypothesis, obscuring true associations ^[4]. Furthermore, specific measurement techniques, such as M-mode echocardiography for aortic root diameter, may be less accurate and underestimate aortic size compared to 2-dimensional imaging, affecting the precision of genetic effect estimates^[4]. Research also indicates limited statistical power to evaluate associations with rare or poorly imputed single-nucleotide polymorphisms (SNPs), which may contribute to the genetic architecture of AAA^[4]. While advanced statistical methods like Mendelian Randomization (MR) are employed to assess for heterogeneity and horizontal pleiotropy, the persistent need for such rigorous diagnostics underscores the inherent complexity and potential for confounding in genetic studies ^[5].

Population Diversity and Generalizability

A significant limitation in understanding AAA genetics is the lack of comprehensive representation across diverse ancestral populations. Many large-scale genetic association studies have predominantly included individuals of European descent, for example, cases recruited from centers in the UK, Australia, and New Zealand ^[2]. While these studies provide valuable insights, findings from such cohorts may not be directly generalizable to other ethnic groups due to differences in genetic architecture, allele frequencies, and environmental exposures. The need for separate large-scale genome-wide association studies (GWAS) in populations like Japanese or African Americans to identify novel susceptibility loci highlights this generalizability concern ^[6]. This disparity in representation means that the full spectrum of genetic risk factors for AAA across global populations remains incompletely understood, potentially limiting the clinical applicability of identified genetic markers to a broader patient base.

Unaccounted Factors and Heritability Gaps

Despite the strong heritability of AAA, current genetic studies explain only a fraction of the total genetic risk, pointing to significant “missing heritability” and remaining knowledge gaps ^[2]. The identified genetic risk alleles often have low odds ratios, suggesting that many other important risk loci for AAA are yet to be discovered ^[2]. Furthermore, the strong influence of non-genetic factors such as advanced age, male gender, smoking, and atherosclerosis are well-established risk factors for AAA^[1]. While these are often accounted for as covariates, the complex interplay between genetic predispositions and environmental exposures (gene-environment interactions) is not always fully elucidated, representing a critical area of ongoing research. Understanding how DNA sequence variants might differ in their contribution to aneurysm risk across various vascular beds (e.g., iliac, lower extremity, cerebral) also represents a significant knowledge gap, emphasizing the need for more comprehensive studies that consider the broader context of aneurysmal disease^[5].

Variants

Genetic variations play a crucial role in an individual’s susceptibility to abdominal aortic aneurysm (AAA), a complex condition influenced by multiple genes and environmental factors. Research has identified several significant genetic loci and specific single nucleotide polymorphisms (SNPs) that impact the risk of developing AAA by affecting processes like cell cycle regulation, extracellular matrix integrity, lipid metabolism, and inflammation. These variants often exert their influence through subtle changes in gene expression or protein function, contributing to the weakening and dilation of the aortic wall.

The 9p21 chromosomal locus, home to the CDKN2B-AS1gene (also known as ANRIL), is a well-established hotspot for cardiovascular diseases, including AAA. Variants such asrs4977574 , rs2891168 , and rs10757274 within CDKN2B-AS1 are associated with an increased risk of AAA. CDKN2B-AS1 is a long non-coding RNA that regulates the expression of neighboring genes, CDKN2A and CDKN2B, which are vital for cell cycle control and cellular senescence. Its dysregulation can lead to uncontrolled cell proliferation or impaired repair mechanisms in the arterial wall, contributing to aneurysm formation, and it has been identified as an AAA risk locus harboring important transcription factor binding sites . These measurement approaches are crucial for identifying the condition and guiding clinical management. While often asymptomatic in its early stages, AAA is a serious public health problem, contributing to numerous hospital admissions, surgical repairs, and deaths annually in the United States^[1].

Key Variants

RS ID	Gene	Related Traits
rs4977574 rs2891168 rs10757274	CDKN2B-AS1	myocardial infarction coronary artery disease asthma, cardiovascular disease brain aneurysm low density lipoprotein cholesterol measurement
rs10455872 rs140570886 rs118039278	LPA	myocardial infarction lipoprotein-associated phospholipase A(2) measurement response to statin lipoprotein A measurement parental longevity
rs3827066	ZNF335	coronary artery disease abdominal aortic aneurysm coronary atherosclerosis occlusion precerebral artery aneurysm
rs12740374 rs7528419	CELSR2	low density lipoprotein cholesterol measurement lipoprotein-associated phospholipase A(2) measurement coronary artery disease body height total cholesterol measurement
rs7994761 rs12857403 rs12869493	LINC00540 - FTH1P7	ascending aorta diameter aortic measurement abdominal aortic aneurysm
rs429358	APOE	cerebral amyloid deposition measurement Lewy body dementia, Lewy body dementia measurement high density lipoprotein cholesterol measurement platelet count neuroimaging measurement
rs73015011	SMARCA4	total cholesterol measurement low density lipoprotein cholesterol measurement level of Sphingomyelin (d40:1) in blood serum abdominal aortic aneurysm
rs4936098 rs7936928	ADAMTS8, ZBTB44-DT	pulse pressure measurement, alcohol drinking systolic blood pressure abdominal aortic aneurysm hypertension aortic aneurysm
rs17486278	CHRNA5	forced expiratory volume, response to bronchodilator FEV/FVC ratio, response to bronchodilator pulmonary function measurement pulmonary artery enlargement, chronic obstructive pulmonary disease emphysema pattern measurement
rs434182	RNU6-1032P - RBBP8	abdominal aortic aneurysm

Classification and Clinical Significance

AAA is classified as a common disease, with a prevalence reaching up to 9% in men over 65 years of age^[1]. The severity of an aneurysm, particularly its risk of rupture, is primarily judged by its size and growth rate, which are critical factors in determining the necessity and timing of intervention^[1]. Rupture is a catastrophic event associated with very high mortality, underscoring the importance of surveillance and timely treatment^[7]. Screening programs, such as the Multicentre Aneurysm Screening Study (MASS), highlight efforts to detect AAA early to mitigate these severe outcomes^[5].

Etiology and Related Terminology

The development of abdominal aortic aneurysm is a multifactorial process, influenced by both genetic and environmental contributions^[2]. Key risk factors for AAA include advanced age, male gender, smoking, atherosclerosis, and a strong family history^[1]. The “familial risk” of AAA is substantial, with studies indicating a high heritability and a significantly increased incidence among first-degree relatives of affected individuals ^[2]. Furthermore, AAA can coexist with and share genetic risk factors with aneurysms in other vascular territories, such as intracranial, thoracic, femoral, and popliteal aneurysms, suggesting a broader predisposition to arterial wall weakness ^[5].

Signs and Symptoms

Insidious Onset and Incidental Discovery

Most abdominal aortic aneurysms (AAAs) typically present asymptomatically, remaining unnoticed until they reach a critical size or rupture, which is a catastrophic event^[1]. This insidious onset means that unruptured AAAs are frequently detected incidentally during imaging studies performed for unrelated conditions, or through targeted population screening programs. The objective diagnostic criteria for AAA involve an infrarenal aortic diameter measuring ≥30 mm or an increase of ≥50% from the normal aortic size^[1]. Given the silent nature of the disease, early detection through screening is paramount for improving diagnostic significance and enabling timely intervention, with studies demonstrating the influence of screening on reducing the incidence of ruptured AAAs^[8], ^[9], ^[10], ^[11].

Manifestations of Acute Rupture

A ruptured abdominal aortic aneurysm is a critical surgical emergency characterized by a wide array of severe clinical presentations, often leading to catastrophic outcomes and very high mortality^[7], ^[1]. While the specific signs can vary, common features typically include sudden, severe abdominal or back pain, hypotension, and a pulsatile abdominal mass, reflecting the acute vascular event. The rapid onset and life-threatening nature of rupture necessitate immediate recognition and intervention, making these acute symptoms crucial red flags for a differential diagnosis that includes other acute abdominal pathologies. Prognostic indicators in this emergency setting are heavily influenced by the patient’s hemodynamic stability and the time to definitive surgical repair^[1].

Risk Factors, Measurement for Prognosis, and Associated Aneurysmal Conditions

The clinical presentation of AAA exhibits significant variability influenced by age, sex, and genetic predisposition, with prevalence reaching up to 9% in men over 65 years ^[1]. Beyond established risk factors like advanced age, male gender, smoking, and atherosclerosis, a substantial genetic component, including variants within genes like DAB2IP and LRP1, contributes significantly to disease susceptibility and familial clustering^[1], ^[2], ^[12], ^[5]. For diagnosed aneurysms, the primary objective measures for prognostic indication and guiding treatment are the aneurysm’s size and its growth rate, as these directly correlate with the risk of rupture^[1]. Furthermore, there is a recognized phenotypic diversity, as individuals with AAA frequently present with co-existing aneurysms in other vascular beds, such as the thoracic aorta, femoral, popliteal arteries, or intracranial arteries, underscoring shared genetic risk factors and the importance of comprehensive vascular assessment ^[13], ^[14], ^[15], ^[16], ^[17].

Abdominal aortic aneurysm (AAA) is a complex condition influenced by a combination of genetic predispositions, environmental factors, and demographic characteristics. The formation and expansion of an aneurysm, defined as a localized enlargement of the aorta, result from a progressive weakening and degradation of the arterial wall.

Genetic Predisposition and Heritability

Abdominal aortic aneurysm exhibits a substantial genetic component, with twin studies estimating its heritability to be as high as 70%^[1].The genetic architecture of AAA is polygenic, involving multiple inherited variants that collectively increase an individual’s susceptibility rather than a single gene defect.

Numerous specific genetic loci have been identified through genome-wide association studies (GWAS) and linkage analyses as contributing to AAA risk. Key variants include a sequence variant within the DAB2IP gene and another in the low-density lipoprotein receptor-related protein 1 (LRP1) gene, both implicated in vascular integrity and lipid metabolism ^[2]. Additionally, a variant on chromosome 9p21 is consistently associated with AAA, alongside myocardial infarction and intracranial aneurysms, highlighting shared biological pathways across different cardiovascular diseases^[18]. Research indicates common genetic risk factors also exist for intracranial, abdominal, and thoracic aneurysms, suggesting a broader genetic susceptibility to aneurysm formation across various arterial beds^[19].

Lifestyle, Comorbidities, and Demographics

Beyond genetic factors, several environmental, lifestyle, and demographic elements significantly contribute to the development of AAA. Smoking is recognized as a primary and modifiable risk factor, directly contributing to aortic wall degradation and inflammation, which are critical processes in aneurysm initiation and expansion^[1]. Atherosclerosis, a condition characterized by plaque buildup in arteries, is another major comorbidity strongly linked to AAA, as it weakens the arterial wall and promotes its pathological remodeling^[1].

The prevalence of AAA rises sharply with age, particularly in men over 65 years, indicating age-related changes in vascular tissue integrity play a crucial role ^[1]. While the precise mechanisms underlying the male predominance are complex, they likely involve hormonal influences and differences in vascular biology, contributing to the higher susceptibility observed in men.

Gene-Environment Interplay

The development of abdominal aortic aneurysm is not solely determined by genetic or environmental factors but rather by their intricate interplay, where genetic predispositions can modify an individual’s response to environmental triggers. A twin study underscored this complexity by demonstrating both significant genetic and environmental contributions to AAA development^[12]. This suggests that while certain individuals may inherit a higher genetic susceptibility, the manifestation of the disease often requires exposure to specific environmental risk factors.

For instance, genetic predispositions can influence behaviors like smoking or physiological traits such as blood pressure, which are potent environmental risk factors for aneurysm formation^[20]. Studies exploring the independence of identified genetic variants from other clinical risk factors for AAA highlight the challenge in disentangling these complex interactions ^[2]. Understanding these gene-environment interactions is crucial for identifying individuals at highest risk and developing targeted prevention strategies that account for both inherited vulnerabilities and modifiable lifestyle factors.

Biological Background

Abdominal aortic aneurysm (AAA) is a serious vascular condition characterized by a localized dilation and weakening of the abdominal aorta. This progressive enlargement of the main artery carrying blood from the heart to the rest of the body below the diaphragm is defined as an increase in aortic diameter of 50% or more, or an infrarenal diameter of 30 mm or greater. It presents a significant public health challenge, as most aneurysms remain asymptomatic until near-rupture or actual rupture, a catastrophic event associated with high mortality.^[1]

Genetic Predisposition and Heritability

Abdominal aortic aneurysm exhibits a substantial genetic component, with studies estimating its heritability at approximately 70%. The risk of developing AAA is significantly elevated in individuals with a family history of the condition, with an eightfold higher incidence observed among siblings of affected patients compared to control groups. This strong familial tendency underscores the importance of inherited factors in disease susceptibility.^{[2] [21] [22] [23] [24]}

Genome-wide association studies (GWAS) have identified several genetic loci and specific gene variants associated with AAA risk. For example, a sequence variant within the DAB2IP gene has been linked to increased susceptibility, as has a variant in the low-density lipoprotein receptor-related protein 1 (LRP1) gene. Furthermore, there is recognized genetic overlap and shared risk factors between AAA and other types of aneurysms, such as intracranial and thoracic aortic aneurysms. While genes like ANRIL and SOX17 are confirmed risk loci for intracranial aneurysms, their shared genetic architecture with AAA suggests common underlying molecular pathways that influence vascular integrity across different arterial beds.^{[1] [2] [17] [21] [21] [5]}

Pathophysiological Mechanisms of Aortic Wall Degradation

The pathogenesis of AAA involves a progressive and destructive remodeling of the aortic wall. This process is characterized by an abnormal degradation of the extracellular matrix (ECM), which is the crucial structural scaffold responsible for maintaining the aorta’s mechanical strength and elasticity. Disruptions in ECM homeostasis lead to the breakdown of essential components like collagen and elastin, critically weakening the vessel wall and making it prone to pathological dilation. ^[21]

This degradation is often triggered or exacerbated by endothelial injury, particularly in response to chronic hemodynamic stress from blood flow. Such injury initiates a complex cascade involving inflammation and the dysregulation of growth factors, including transforming growth factor-beta (TGF-β). While TGF-β plays a role in normal tissue repair, its aberrant signaling in pathological contexts can contribute to excessive ECM degradation and an imbalance in tissue remodeling. Ultimately, these processes lead to a loss of the aorta’s intrinsic elasticity, increased arterial stiffness, and a heightened risk of aneurysm expansion and rupture.^{[21] [25]}

Cellular and Molecular Pathways in Aneurysm Formation

At the cellular level, AAA development involves significant dysfunction of key cell types within the vascular wall, notably vascular endothelial cells (vECs) and vascular smooth muscle cells (VSMCs). Genetic predispositions can lead to altered gene expression patterns and regulatory networks in these cells, compromising their normal functions in maintaining vascular integrity. This includes disruptions in cellular processes such as proliferation, migration, and apoptosis, which collectively contribute to an imbalance between tissue repair and destructive processes within the aortic wall.^{[20] [21]}

Key biomolecules play critical roles in these cellular and molecular pathways. The DAB2IP protein, for instance, is involved in signal transduction, cell growth, and programmed cell death, while LRP1 is a receptor integral to lipid metabolism and cellular signaling. TGF-β also acts as a crucial signaling molecule, influencing cell-ECM interactions and the inflammatory state of the aorta. Abnormalities in the functions or regulatory networks of these and other critical proteins contribute to the progressive dilation and weakening of the abdominal aorta, setting the stage for aneurysm development and its associated risks.^{[1] [2] [21]}

Systemic Influences and Risk Factors

The development and progression of abdominal aortic aneurysm are significantly influenced by systemic factors that interact with an individual’s genetic vulnerabilities. Established clinical risk factors such as advanced age, male gender, smoking, and atherosclerosis are paramount in exacerbating the underlying biological mechanisms of AAA. These systemic conditions contribute to a broader vascular environment conducive to aneurysm formation and expansion.^[1]

Genetic predispositions for traits like smoking and elevated blood pressure have also been identified as independent genetic risk factors for aneurysms. These genetic influences underscore the complex interplay between an individual’s inherited susceptibility and lifestyle or environmental exposures. Systemic factors contribute to homeostatic disruptions within the vascular system, including chronic inflammation and oxidative stress, which further accelerate the pathological remodeling and degradation of the aortic wall. Understanding these systemic interactions is crucial for a comprehensive understanding of AAA pathogenesis and for developing effective preventive and therapeutic strategies.^{[1] [20]}

Pathways and Mechanisms

Abdominal aortic aneurysm (AAA) development is a complex process driven by genetic predispositions, cellular dysfunction, and intricate molecular interactions within the aortic wall. The pathogenesis involves a cascade of events encompassing specific gene regulation, altered vascular smooth muscle cell (VSMC) behavior, and the integration of various signaling pathways that collectively compromise aortic integrity.

Genetic Susceptibility and Transcriptional Regulation

Genetic factors play a foundational role in determining an individual’s susceptibility to AAA, influencing critical transcriptional programs. For instance, variants within the DAB2IP gene have been identified as conferring susceptibility to AAA ^[1]. As a Ras-GTPase activating protein, DAB2IP is involved in intracellular signaling cascades that regulate cell growth, survival, and apoptosis, suggesting that its dysregulation can impact the cellular balance necessary for maintaining aortic wall homeostasis.

Beyond direct AAA associations, genes such as ANRIL and SOX17, recognized for their roles in intracranial aneurysm risk, also contribute to broader arterial vulnerability, hinting at shared underlying pathways^[20]. SOX17 is a key transcription factor vital for vascular development and the differentiation of VSMCs, meaning its genetic variants can alter gene regulation critical for arterial structure. Similarly, ANRIL, a long non-coding RNA, exerts regulatory control over gene expression, potentially influencing cellular processes like proliferation and inflammatory responses that contribute to aneurysm formation. Furthermore, genetic variation in the 3’-BCL11Bgene desert has been linked to increased carotid-femoral pulse wave velocity, indicating its involvement in regulating genes that impact aortic stiffening and overall cardiovascular risk^[26].

Vascular Smooth Muscle Cell Homeostasis and Dysfunction

The integrity of the aortic wall is critically dependent on the proper function and phenotypic state of vascular smooth muscle cells (VSMCs). Research indicates that genetic factors significantly regulate atherosclerosis-relevant phenotypes in human VSMCs, which are crucial for maintaining the structural and functional properties of the aorta^[27]. Dysregulation of these genetically influenced VSMC functions, including their proliferation, migration, and the synthesis and degradation of extracellular matrix components, leads to maladaptive remodeling of the arterial wall. This process compromises the aorta’s elasticity and tensile strength, setting the stage for aneurysm development.

Specific genetic variants can impact the balance of VSMC activity, leading to an imbalance in extracellular matrix (ECM) turnover. This can result in excessive degradation of elastin and collagen, key structural proteins, or an impaired ability of VSMCs to repair and synthesize new matrix components. Such dysregulation represents a central mechanism in AAA pathogenesis, as the progressive weakening of the vessel wall promotes its pathological dilation. Understanding these genetically mediated alterations in VSMC homeostasis provides critical insights into potential therapeutic targets aimed at restoring aortic wall integrity.

Pathway Crosstalk and Systems-Level Vascular Remodeling

The development of abdominal aortic aneurysm is not an isolated event but rather an outcome of interconnected molecular pathways and systemic interactions. Abdominal aortic aneurysm shares common genetic risk factors with other forms of aneurysms, such as intracranial and thoracic aortic aneurysms^[20]. This overlap underscores significant pathway crosstalk and network interactions among genes and their regulatory mechanisms that collectively govern overall vascular health and remodeling across different arterial beds. Genes identified in one aneurysm type, likeANRIL and SOX17 in intracranial aneurysms, often have broader implications for vascular susceptibility, highlighting a shared molecular etiology.

This systems-level integration of genetic influences and their associated signaling cascades contributes to the emergent property of aortic wall vulnerability. The interplay extends beyond direct effects on VSMCs and the ECM to encompass broader inflammatory responses and biomechanical alterations within the aorta ^[26]. Deciphering these complex, interconnected regulatory networks is essential for identifying novel therapeutic targets that can intervene at multiple points in the disease process, offering the potential for more effective strategies to prevent and treat AAA by addressing its multifaceted genetic and mechanistic underpinnings.

Population Studies

Population studies are fundamental to understanding the epidemiology, risk factors, and genetic architecture of abdominal aortic aneurysm (AAA). These investigations range from large-scale cohort analyses and genetic studies to cross-population comparisons and evaluations of screening programs, providing comprehensive insights into the disease’s impact and progression.

Prevalence, Incidence, and Established Risk Factors

Abdominal aortic aneurysm is a common vascular condition, particularly affecting older men, with prevalence rates reaching up to 9% in men over 65 years of age^[1]. It represents a significant public health challenge, contributing to over 150,000 hospital admissions, 40,000 repair surgeries, and 15,000 deaths annually in the United States ^[1]. Epidemiological studies consistently identify advanced age, male sex, and smoking as primary risk factors for AAA development ^[1]. Additionally, atherosclerosis and a family history of AAA are recognized as strong contributors to the disease^[1]. Population risk factor estimates, derived from studies such as case-control analyses utilizing electronic medical records, have been instrumental in quantifying these associations . Furthermore, large cohort studies like the Million Veteran Program highlight the increased prevalence of comorbidities such as diabetes mellitus, statin therapy, and current or former smoking among individuals with AAA compared to controls^[5].

Genetic Epidemiology and Large-Scale Cohort Studies

The genetic contribution to abdominal aortic aneurysm susceptibility is substantial, with twin studies estimating heritability to be as high as 70%^[1]. Family studies reinforce this, showing that individuals with a first-degree relative affected by AAA face a 2- to 11-fold increased risk of developing the condition themselves ^[2], with some analyses indicating an eightfold higher lifetime prevalence among siblings of aneurysm patients^[28]. Large-scale genome-wide association studies (GWAS) have been pivotal in unraveling the genetic architecture of AAA. For example, a meta-analysis of GWAS identified four new disease-specific risk loci^[21], and another study pinpointed a sequence variant within the DAB2IP gene as conferring susceptibility ^[1]. The Million Veteran Program, a comprehensive cohort study, has extensively explored the genetic underpinnings of AAA, analyzing millions of genetic variants across thousands of cases and controls ^[5]. Beyond AAA-specific genetics, research has also identified shared genetic risk factors among abdominal, intracranial, and thoracic aneurysms, suggesting common biological pathways that predispose individuals to different forms of arterial aneurysm^[19].

Cross-Population Comparisons and Ancestry Differences

Population-level analyses reveal that abdominal aortic aneurysm predominantly affects white populations^[2]. However, studies investigating ancestry-specific effects are crucial for a complete understanding of disease prevalence and risk factors across diverse ethnic groups. For instance, research has specifically examined the genetic architecture of aortic root diameter in African Americans through studies such as the HyperGEN study . These cross-population comparisons are vital for identifying how varying genetic backgrounds and environmental exposures contribute to AAA risk. Methodological considerations in such studies include rigorous ethical oversight, with Institutional Review Board (IRB) approval and informed consent obtained from all participants, ensuring the representativeness and generalizability of findings .

Screening Initiatives and Public Health Impact

Given that most abdominal aortic aneurysms remain asymptomatic until they are near rupture or rupture, a catastrophic event associated with very high mortality, population-based screening programs are critical for early detection and intervention^[1]. Randomized controlled trials, such as the Multicentre Aneurysm Screening Study (MASS), have provided robust evidence on the effectiveness of screening in reducing mortality among men . Another population-based randomized controlled trial also evaluated the impact of screening on AAA mortality . Despite the established benefits, studies indicate that screening for AAA remains underutilized among eligible populations, such as Medicare beneficiaries, often leading to late diagnoses^[8]. Organizations like the US Preventive Services Task Force issue recommendations for AAA screening, underscoring its importance in public health strategies to prevent rupture and improve patient outcomes ^[9].

Frequently Asked Questions About Abdominal Aortic Aneurysm

These questions address the most important and specific aspects of abdominal aortic aneurysm based on current genetic research.

---

1. My grandfather had an AAA; does that mean I’m automatically at high risk?

Having a first-degree relative with an AAA significantly increases your risk, potentially by 2- to 11-fold. This is because AAA has a strong genetic component, with heritability estimated as high as 70%. While it doesn’t mean you’ll definitely get it, your risk is substantially higher, making awareness and proactive discussions with your doctor important.

2. Can my healthy lifestyle overcome a strong family history of AAA?

While genetics play a major role, accounting for up to 70% of the heritability, lifestyle factors are also crucial. Smoking, for instance, is a key risk factor. Maintaining a healthy lifestyle, including not smoking and managing conditions like atherosclerosis, can help mitigate your genetic predisposition and reduce your overall risk.

3. I feel totally healthy; could I still have a dangerous AAA?

Yes, unfortunately. Abdominal aortic aneurysms are particularly challenging because they often remain asymptomatic until they are very large or rupture. Feeling healthy doesn’t rule out the presence of an aneurysm, which is why early detection through screening is so vital for at-risk individuals.

4. As a white man, am I more likely to get an AAA than my diverse friends?

Research indicates that AAA predominantly affects white populations and is more common in men, especially those over 65. The prevalence can be as high as 9% in men over 65. Your background, combined with male gender, does put you in a higher-risk demographic compared to other groups.

5. If I smoke, am I almost guaranteed to get an AAA if it runs in my family?

Smoking is a critical risk factor that significantly interacts with a family history of AAA. While it doesn’t guarantee you’ll develop one, combining these two factors dramatically increases your susceptibility. Quitting smoking is one of the most impactful steps you can take to lower your risk, even with a genetic predisposition.

6. My aunt had a brain aneurysm; does that mean I’m also at risk for an AAA?

There’s growing evidence for shared genetic risk factors across different types of aneurysms, including abdominal, intracranial (brain), and thoracic aneurysms. So, yes, if your aunt had a brain aneurysm, it suggests you might have some common genetic predispositions that could also increase your risk for an AAA.

7. Would a genetic test tell me if I’ll definitely get an AAA?

A genetic test can identify specific risk variants, such as those in the DAB2IP or LRP1 genes, which indicate increased susceptibility. However, genetics are complex, and having these variants doesn’t mean you’ll definitely develop an AAA. Many factors, including other genes and environmental influences, contribute to the overall risk.

8. If AAA is mostly genetic, why don’t all family members get it?

While AAA has high heritability, meaning a large portion of the risk comes from genetics, it’s not purely deterministic. Heritability reflects the population-level influence of genes, not a guarantee for individuals. Environmental factors, other genetic variations, and lifestyle choices also play a role, explaining why not everyone in a family will develop the condition.

9. I have atherosclerosis; does that make my AAA risk much worse?

Yes, atherosclerosis is a key risk factor for developing an AAA. This condition, characterized by plaque buildup in your arteries, contributes to the weakening and dilation of the aortic wall. Managing your atherosclerosis through lifestyle and medical treatment is crucial for reducing your AAA risk.

10. With my family history, when should I start thinking about getting checked for AAA?

Given your family history and the silent nature of AAA until potential rupture, it’s wise to discuss screening with your doctor. Current guidelines often recommend screening for men over 65, especially those with a family history or who have smoked. Your doctor can help determine the appropriate timing for you.

---

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Gretarsdottir S, et al. “Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.”Nat Genet, vol. 42, no. 7, 2010, pp. 891–897.

[2] Bown MJ, et al. “Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1.”Am J Hum Genet, vol. 89, no. 5, 2011, pp. 642–647.

[3] Helgadottir, A, et al. “The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.”Nat Genet, 2008. PMID: 2008.

[4] Vasan, R. S., et al. “Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.” JAMA, vol. 302, no. 2, 2009, pp. 168-178, PMID: 19584346.

[5] Klarin D, et al. “Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program.”Circulation, vol. 142, no. 17, 2020, pp. 1652–1662.

[6] Ishigaki, K., et al. “Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.” Nat Genet, 2020, PMID: 32514122.

[7] Assar, A. N., and C. K. Zarins. “Ruptured abdominal aortic aneurysm: a surgical emergency with many clinical presentations.”Postgrad Med J, vol. 85, no. 1003, 2009, pp. 268-273.

[8] Mell, M. W., et al. “Late diagnosis of abdominal aortic aneurysms substantiates underutilization of abdominal aortic aneurysm screening for Medicare beneficiaries.”J Vasc Surg, vol. 50, no. 1, 2009, pp. 15-20.

[9] Owens, D. K., et al. “Screening for abdominal aortic aneurysm: US Preventive Services Task Force recommendation statement.”JAMA, vol. 322, no. 17, 2019, pp. 1702-1710.

[10] Scott, R. A., et al. “Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results.”Br J Surg, vol. 82, no. 8, 1995, pp. 1045-1049.

[11] Ashton, H. A., et al. “The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.”Lancet, vol. 360, no. 9334, 2002, pp. 1005-1011.

[12] Jones GT, et al. “Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci.”Circ Res, vol. 119, no. 11, 2016, pp. 1238–1247.

[13] Larsson, E., et al. “High frequency of thoracic aneurysms in patients with abdominal aortic aneurysms.” Ann Surg, vol. 253, no. 1, 2011, pp. 180-184.

[14] Norrgard, O., et al. “Co-existence of abdominal aortic aneurysms and intracranial aneurysms.” Acta Neurochir (Wien), vol. 87, no. 1-2, 1987, pp. 34-39.

[15] Miyazawa, N., et al. “Risk factors for the association of intracranial and aortic aneurysms.” Acta Neurochir (Wien), vol. 149, no. 2, 2007, pp. 221-229.

[16] Diwan, A., et al. “Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysm.”J Vasc Surg, vol. 48, no. 5, 2008, pp. 1198-1203.

[17] van ‘t Hof FN, et al. “Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms.” J Am Heart Assoc, vol. 5, no. 7, 2016, e003264.

[18] Bown, MJ, et al. “Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm.”Circ Cardiovasc Genet, 2008. PMID: 20031540.

[19] Ruigrok, YM, Elias R, Wijmenga C, Rinkel GJ. “A comparison of genetic chromosomal loci for intracranial, thoracic aortic, and abdominal aortic aneurysms in search of common genetic risk factors.” Cardiovasc Pathol, 2008.

[20] Bakker MK, et al. “Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors.” Nat Genet, vol. 52, no. 12, 2020, pp. 1303–1314.

[21] Jones, G. T., et al. “Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci.”Circ Res, 2017.

[22] Johansen K, Koepsell T. “Familial tendency for abdominal aortic aneurysms.” JAMA, vol. 256, no. 14, 1986, pp. 1934–1936.

[23] Majumder PP, et al. “On the inheritance of abdominal aortic aneurysm.”Am J Hum Genet, vol. 48, no. 1, 1991, pp. 164–170.

[24] Powell JT, Greenhalgh RM. “Multifactorial inheritance of abdominal aortic aneurysm.”Eur J Vasc Surg, vol. 1, no. 1, 1987, pp. 29-32.

[25] Helgadottir, A., et al. “Genome-wide analysis yields new loci associating with aortic valve stenosis.” Nat Commun, 2018.

[26] Mitchell GF, et al. “Common genetic variation in the 3’-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.”Circ Cardiovasc Genet, vol. 4, no. 6, 2011, pp. 627–636.

[27] Aherrahrou R, et al. “Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells.”Circ Res, vol. 127, no. 12, 2020, pp. 1548–1560.

[28] Ogata T, et al. “The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in.”J Vasc Surg, vol. 42, no. 5, 2005, pp. 891-897.